Home » Topics » BioWorld Science

BioWorld Science
RSS

BARDA funding to support pediatric studies of Stratagraft for thermal burns

Oct. 16, 2018

[18F]HTK-01174 shows promise for PET imaging of prostate cancer

Oct. 16, 2018

Dupixent reduces nasal polyp size and nasal congestion severity in phase III trials

Oct. 16, 2018

Cellect reports promising data from phase I/II study of ApoGraft technology

Oct. 16, 2018

TherapyX and Intravacc partner to develop Ngoxim prophylactic vaccine against gonorrhea

Oct. 16, 2018

Soligenix receives recommendation to continue phase III FLASH study of SGX-301

Oct. 16, 2018

Phase I/II study of KB-103 meets all primary efficacy and safety endpoints at interim data analysis

Oct. 16, 2018

SQZ Biotech expands cellular therapy partnership with Roche

Oct. 16, 2018

Hefei Amvite Pharmaceutical and collaborators identify platelet adhesion inhibitors

Oct. 16, 2018

Shanghai De Novo Pharmatech identifies Wee1-like protein kinase inhibitors

Oct. 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...